J.M.P. Holly

1.5k total citations
33 papers, 1.2k citations indexed

About

J.M.P. Holly is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cancer Research. According to data from OpenAlex, J.M.P. Holly has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in J.M.P. Holly's work include Growth Hormone and Insulin-like Growth Factors (29 papers), Metabolism, Diabetes, and Cancer (8 papers) and Cancer, Hypoxia, and Metabolism (7 papers). J.M.P. Holly is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (29 papers), Metabolism, Diabetes, and Cancer (8 papers) and Cancer, Hypoxia, and Metabolism (7 papers). J.M.P. Holly collaborates with scholars based in United Kingdom, Norway and Sweden. J.M.P. Holly's co-authors include Claire M. Perks, S C Cwyfan-Hughes, S. C. Cwyfan Hughes, David B. Dunger, Svein Inge Helle, Per Eystein Lønning, David Gunnell, George Davey Smith, Ellen G Vernon and Stephen Frankel and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Oncogene and Endocrinology.

In The Last Decade

J.M.P. Holly

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.M.P. Holly United Kingdom 21 785 395 203 201 184 33 1.2k
Juan J. Heinrich Argentina 17 805 1.0× 469 1.2× 122 0.6× 541 2.7× 172 0.9× 35 1.5k
M O Savage United Kingdom 23 1.2k 1.5× 501 1.3× 239 1.2× 557 2.8× 76 0.4× 67 1.7k
Raphaël Rappaport France 22 636 0.8× 375 0.9× 286 1.4× 284 1.4× 74 0.4× 32 1.3k
Ronnie J. Barkey Israel 20 649 0.8× 299 0.8× 100 0.5× 180 0.9× 47 0.3× 42 964
M C Postel-Vinay France 23 1000 1.3× 434 1.1× 127 0.6× 325 1.6× 185 1.0× 40 1.5k
Philip Murray United Kingdom 18 580 0.7× 528 1.3× 190 0.9× 376 1.9× 114 0.6× 47 1.3k
Peter F. Bruning Netherlands 17 513 0.7× 549 1.4× 94 0.5× 213 1.1× 781 4.2× 29 1.9k
Kuk‐Wha Lee United States 19 467 0.6× 645 1.6× 54 0.3× 138 0.7× 108 0.6× 26 1.3k
C Lassarre France 22 1.6k 2.0× 786 2.0× 383 1.9× 360 1.8× 81 0.4× 33 2.0k
Antony Lafferty Australia 16 658 0.8× 558 1.4× 86 0.4× 367 1.8× 189 1.0× 30 1.6k

Countries citing papers authored by J.M.P. Holly

Since Specialization
Citations

This map shows the geographic impact of J.M.P. Holly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M.P. Holly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M.P. Holly more than expected).

Fields of papers citing papers by J.M.P. Holly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M.P. Holly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M.P. Holly. The network helps show where J.M.P. Holly may publish in the future.

Co-authorship network of co-authors of J.M.P. Holly

This figure shows the co-authorship network connecting the top 25 collaborators of J.M.P. Holly. A scholar is included among the top collaborators of J.M.P. Holly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M.P. Holly. J.M.P. Holly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Li, et al.. (2015). Hyperglycaemia-induced chemoresistance in breast cancer cells: role of the estrogen receptor. Endocrine Related Cancer. 23(2). 125–134. 25 indexed citations
2.
3.
Perks, Claire M., et al.. (2007). IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells. Oncogene. 26(40). 5966–5972. 94 indexed citations
4.
Perks, Claire M. & J.M.P. Holly. (2003). Actions of IGFBP on Epithelial Cancer Cells: Potential for New Therapeutic Targets. Hormone and Metabolic Research. 35(11/12). 828–835. 10 indexed citations
5.
Helle, Svein Inge, Jürgen Geisler, Gun Anker, et al.. (2001). Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer. British Journal of Cancer. 85(2). 147–151. 10 indexed citations
6.
Jefferson, Kieran, Raj Persad, & J.M.P. Holly. (2000). Apoptosis and its relevance to urologists. British Journal of Urology. 86(5). 598–606. 2 indexed citations
7.
Holmes, Robert, Helen Porter, P.V. Newcomb, J.M.P. Holly, & P. W. Soothill. (1999). An Immunohistochemical Study of Type I Insulin-like Growth Factor Receptors in the Placentae of Pregnancies with Appropriately Grown or Growth Restricted Fetuses. Placenta. 20(4). 325–330. 34 indexed citations
8.
9.
Mason, H. D., et al.. (1998). Potent Inhibition of Human Ovarian Steroidogenesis by Insulin-Like Growth Factor Binding Protein-4 (IGFBP-4). The Journal of Clinical Endocrinology & Metabolism. 83(1). 284–287. 41 indexed citations
10.
Gunnell, David, George Davey Smith, J.M.P. Holly, & Stephen Frankel. (1998). Leg length and risk of cancer in the Boyd Orr cohort. BMJ. 317(7169). 1350–1351. 75 indexed citations
11.
Ogilvy‐Stuart, Amanda, Simon Hands, J.M.P. Holly, et al.. (1998). Insulin, Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1, Growth Hormone, and Feeding in the Newborn. The Journal of Clinical Endocrinology & Metabolism. 83(10). 3550–3557. 96 indexed citations
12.
Mason, H. D., et al.. (1997). The insulin-like growth factors (IGFs) in follicular fluid are predominantly bound in the ternary complex. Journal of Endocrinology. 155(3). R1–R4. 23 indexed citations
13.
Ross, Richard, S. L. Chew, M Yateman, et al.. (1996). Expression of IGF-I and IGF-binding protein genes in cirrhotic liver. Journal of Endocrinology. 149(2). 209–216. 32 indexed citations
14.
15.
16.
17.
Hughes, S. C. Cwyfan, John Wass, & J.M.P. Holly. (1993). Two site-specific radioimmunoassays which demonstrate the presence of proteolytically modified insulin-like growth factor-binding protein-3 in the circulation. Journal of Endocrinology. 137(2). 321–328. 13 indexed citations
18.
Hughes, S. C. Cwyfan, et al.. (1992). The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery. Journal of Endocrinology. 135(1). 135–145. 92 indexed citations
19.
Perry, L. A., et al.. (1991). Purification and assay of insulin-like growth factor-binding protein-1: measurement of circulating levels throughout pregnancy. Journal of Endocrinology. 128(1). 161–168. 57 indexed citations
20.
Holly, J.M.P., David B. Dunger, Julie Edge, et al.. (1990). Insulin‐like Growth Factor Binding Protein‐1 Levels in Diabetic Adolescents and their Relationship to Metabolic Control. Diabetic Medicine. 7(7). 618–623. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan J. Heinrich Breakdown of academic impact, for papers by M O Savage Breakdown of academic impact, for papers by Raphaël Rappaport Breakdown of academic impact, for papers by Ronnie J. Barkey Breakdown of academic impact, for papers by M C Postel-Vinay Breakdown of academic impact, for papers by Philip Murray Breakdown of academic impact, for papers by Peter F. Bruning Breakdown of academic impact, for papers by Kuk‐Wha Lee Breakdown of academic impact, for papers by C Lassarre Breakdown of academic impact, for papers by Antony Lafferty
Rankless by CCL
2026